2 great ASX stocks to buy and 2 to avoid in 2015

Avoid disappointment by focusing on stocks such as Macquarie Group Ltd (ASX:MQG) and Primary Health Care Limited (ASX:PRY) which aren't outrageously priced.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Famous investor Warren Buffett hasn't made his billions by buying expensive, overpriced shares. On the contrary, he's waited patiently to buy quality businesses when they are below what he considers their fair value, or when they are close to fair value but he has gained insights into a business' comparative advantage which can allow for meaningful growth for years to come.

Buy reasonably priced quality stocks

Macquarie Group Ltd (ASX: MQG) is forecast to produce strong earnings growth over the next few years, yet the investment bank's shares trade on a relatively undemanding price-to-earnings (PE) multiple (based on data provided by Morningstar) for financial year 2015 of 14.3x.

Primary Health Care Limited (ASX: PRY) offers exposure to defensive health care sectors including general practice and pathology which continue to enjoy a nice tailwind. Unlike some of its premium priced peers, Primary's shares trade on a forecast PE of just 12.8x.

Avoid expensive growth stocks

Navitas Limited (ASX: NVT) has built itself an enviable position within the education services sector thanks to its market-leading university pathway course offerings. Despite the quality of this company, with the stock trading on a PE of 20.6x current year earnings, the shares looks fully priced considering growth expectations and regulatory risks.

Ramsay Health Care Limited (ASX: RHC) remains a market darling amongst investors. With a total shareholder return over the past three years of 47.8% per annum and strong growth in earnings forecast over the next few years that's certainly understandable. Looking out as far as financial year 2017 however, the forecast PE of 23.2x makes the stock look fully valued.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned.  

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »